this is incredibly impressive.
assuming next quarter remains steady at roughly 1.5 m earnings, you are looking at 12 million earnings on a PA basis.
with the 128.8 million shares on issue at 0.285c currently that is a PE of 3.
very few stocks on the whole ASX can boast a PE of 3 let alone profitability at that price.
while the merger does skew things, as long as earnings are steady, confidence will be bread and people will flock to buy. Investors follow the money.
my only question is the integrity of management as this is a topic I haven't reviewed yet, but this is a great fundamental buy as I am concerned.
- Forums
- ASX - By Stock
- VIT
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
-0.005(5.05%) |
Mkt cap ! $54.13M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.4¢ | $4.42K | 46.71K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11077 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 1855 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11077 | 0.090 |
3 | 87509 | 0.089 |
2 | 15978 | 0.088 |
1 | 57377 | 0.087 |
2 | 86780 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 1855 | 1 |
0.099 | 15607 | 1 |
0.100 | 10000 | 1 |
0.105 | 78267 | 4 |
0.110 | 23630 | 1 |
Last trade - 15.37pm 15/07/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online